An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer

✍ Scribed by H Bonnefoi; L Biganzoli; T Cufer; L Mauriac; A Hamilton; P Schaefer; M Piccart

• Book ID: 110314020
• Publisher: Springer US
• Year: 2001
• Tongue: English
• Weight: 90 KB
• Volume: 70
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1023/a:1012530607649